Vesalius Therapeutics

0 followers


Vesalius Therapeutics is focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness.

Industries

Employees

11-50

Links


Org chart

Chris Cotsapas
Senior Vice President, Platform Development
Lisa Brown
Senior Vice President, Strategy And Operations
Ben Munoz
SVP, Head of Drug Discovery
John Hulburt
VP of Finance
William Oemler
Director of Software Engineering
Patrick Faloon
Director, Head of Assays & HTS

Board & advisors

Doug Cole
Director
Lee Rubin
Scientific Advisor
Paola Arlotta
Scientific Advisor
Percy Carter
Scientific Advisor
John A. Todd
Scientific Advisor
Wendy Chung
Scientific Advisor
Justin Ichida
Scientific Advisor
Tanya Fischer
Scientific Advisor